Perrigo (PRGO) Net Income towards Common Stockholders (QoQ) (2013 - 2026)
Perrigo (PRGO) Net Income towards Common Stockholders (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Perrigo | 1.42 Bn | 1.06 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -148.57% |
| Dec 31, 2025 | 32.69% |
| Sep 27, 2025 | 34.18% |
| Jun 28, 2025 | -21.54% |
| Mar 29, 2025 | -116.67% |
| Dec 31, 2024 | 11.76% |
| Sep 28, 2024 | -25.93% |
| Jun 29, 2024 | -28.57% |
| Mar 30, 2024 | 54.35% |
| Dec 31, 2023 | -283.33% |
| Sep 30, 2023 | -140.00% |
| Jul 1, 2023 | 73.68% |
| Apr 1, 2023 | 82.73% |
| Dec 31, 2022 | -507.41% |
| Oct 1, 2022 | 1,450.00% |
| Jul 2, 2022 | 81.82% |
| Apr 2, 2022 | 95.11% |
| Dec 31, 2021 | -350.00% |
| Oct 2, 2021 | -109.23% |
| Jul 3, 2021 | 53.54% |